Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
The DOI matches its Crossref record; 23 of the 26 references it cites were found in a registry or an index.
Abstract
We analyzed data from the National Nosocomial Infections Surveillance (NNIS) System from 1986-2003 to determine the epidemiology of gram-negative bacilli in intensive care units (ICUs) for the most frequent types of hospital-acquired infection: pneumonia, surgical site infection (SSI), urinary tract infection (UTI), and bloodstream infection (BSI). We analyzed >410,000 bacterial isolates associated with hospital-acquired infections in ICUs during 1986-2003. In 2003, gram-negative bacilli were associated with 23.8% of BSIs, 65.2% of pneumonia episodes, 33.8% of SSIs, and 71.1% of UTIs. The percentage of BSIs associated with gram-negative bacilli decreased from 33.2% in 1986 to 23.8% in 2003. The percentage of SSIs associated with gram-negative bacilli decreased from 56.5% in 1986 to 33.8% in 2003. The percentages pneumonia episodes and UTIs associated with gram-negative bacilli remained constant during the study period. The proportion of ICU pneumonia episodes associated with Acinetobacter species increased from 4% in 1986 to 7.0% in 2003 (P<.001, by the Cochran-Armitage chi2 test for trend). Significant increases in resistance rates were uniformly seen for selected antimicrobial-pathogen combinations. Gram-negative bacilli are commonly associated with hospital-acquired infections in ICUs. The proportion of Acinetobacter species associated with ICU pneumonia increased from 4% in 1986 to 7.0% in 2003.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a group, these organisms are the most common etiology of nosocomial infections, including most cases of hospital-acquired pneumonia, ventilator-associated pneumonia and healthcare-associated pneumonia, and they are important causes of morbidity and death in hospitalized patients (1).”
From Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia (2017) · cites this paper as [1]
Citations
Cites
Vincent, J.-L. (1995) · JAMA · doi:10.1001/jama.1995.03530080055041 · Cited by 1,632 · cited 1×
“A recent review by Archibald [9] showed that the types of pathogens encountered in health care institutions in North America, Europe, Asia, Australia, and even Africa are, for the most part, similar [10-14].”
Hospital Epidemiology and Infection Control
Mayhall, C. G. (2011) · Cited by 1,179
National nosocomial infections surveillance system (NNIS): Description of surveillance methods
Emori, T. G., Culver, D. H., Horan, T. C., Jarvis, W. R., White, J. W., Olson, D. R., Banerjee, S., Edwards, J. R., Martone, W. J., Gaynes, R. P., et al. (1991) · American Journal of Infection Control · doi:10.1016/0196-6553(91)90157-8 · Cited by 832
Self-citationSurveillance nosokomialer Infektionen
Gastmeier (2004) · Therapeutische Umschau · doi:10.1024/0040-5930.61.3.204 · Cited by 509
Epidemiology and control of nosocomial infections in adult intensive care units
Weinstein, R. A. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90366-6 · Cited by 300 · cited 1×
“the 4 most frequent types of hospital-acquired infection: pneumonia, surgical site infection (SSI), urinary tract infection (UTI), and bloodstream infection (BSI) [1].”
BackgroundSelf-citationMultidrug-Resistant Acinetobacter baumannii
Abbo, A., Navon-Venezia, S., Hammer-Muntz, O., Krichali, T., Siegman-Igra, Y., & Carmeli, Y. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040001 · Cited by 285 · cited 1×
“Acinetobacter organisms are intrinsically resistant to many antimicrobials and can acquire resistance to others [7].”
BackgroundHOSPITAL ACQUIRED INFECTIONS: KNOWLEDGE ABOUT IT AND ITS PREVENTION
QAYYUM, S., WAQAS, B., & SATTAR, A. (2010) · The Professional Medical Journal · doi:10.29309/tpmj/2010.17.02.2211 · Cited by 256
MAGNITUDE AND PREVENTION OF NOSOCOMIAL INFECTIONS IN THE INTENSIVE CARE UNIT
Fridkin, S. K., Welbel, S. F., & Weinstein, R. A. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70366-4 · Cited by 225 · cited 1×
“A recent review by Archibald [9] showed that the types of pathogens encountered in health care institutions in North America, Europe, Asia, Australia, and even Africa are, for the most part, similar [10-14].”
BackgroundSelf-citationStreit, J. M., Jones, R. N., Sader, H. S., & Fritsche, T. R. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.12.019 · Cited by 191
Syncope and orthostatic hypotension
Atkins, D., Hanusa, B., Sefcik, T., & Kapoor, W. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90012-m · Cited by 172
Research works printed but not linked: 2
- 1991, The American journal of medicine, 91, 86
- Richards, 2003, Annals of surgery, 237, 358, 10.1097/00000658-200303000-00009 · doi:10.1097/00000658-200303000-00009
Cited by
Items 101–200 of 1,000
Du, X., Xu, X., Yao, J., Deng, K., Chen, S., Shen, Z., Yang, L., & Feng, G. (2019) · American Journal of Infection Control · doi:10.1016/j.ajic.2019.03.003 · Cited by 163
“Resistance is mainly due to overexpression of that causes nosocomial infections, predominantly bloodstream and respiratory infections, including ventilator-associated pneumonia, especially among critically ill patients.(1,2) Carbapenems are commonly used for the treatment of serious infections caused by A baumannii.”
BackgroundRecent advances in the synthetic and medicinal perspective of quinolones: A review
Dhiman, P., Arora, N. R., Thanikachalam, P. V., & Monga, V. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103291 · Cited by 160
Two Component Regulatory Systems and Antibiotic Resistance in Gram-Negative Pathogens
Bhagirath, A. Y., Li, Y., Patidar, R. K., Yerex, K., Ma, X., Kumar, A., & Duan, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071781 · Cited by 170
Epidemiology of intensive care unit-acquired urinary tract infections
Bagshaw, S. M., & Laupland, K. B. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000200292.37909.e0 · Cited by 152
Incidence and bacteriology of burn infections at a military burn center
Keen, E. F., ROBINSON, B. J., Hospenthal, D. R., Aldous, W. K., Wolf, S. E., Chung, K. K., & Murray, C. K. (2010) · Burns · doi:10.1016/j.burns.2009.10.012 · Cited by 151
Inhaled Antibiotics for Gram-Negative Respiratory Infections
Wenzler, E., Fraidenburg, D. R., Scardina, T., & Danziger, L. H. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-15 · Cited by 144
Tam, V. H., Chang, K., Abdelraouf, K., Brioso, C. G., Ameka, M., McCaskey, L. A., Weston, J. S., Caeiro, J., & Garey, K. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01446-09 · Cited by 147
Feizabadi, M. M., Fathollahzadeh, B., Taherikalani, M., Rasoolinejad, M., Sadeghifard, N., Aligholi, M., Soroush, S., & Mohammadi-Yegane, S. (2008) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2008.274 · Cited by 147
Adams‐Haduch, J. M., Paterson, D. L., Sidjabat, H. E., Pasculle, A. W., Potoski, B. A., Muto, C. A., Harrison, L. H., & Doi, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00570-08 · Cited by 145
“Several outbreaks caused by multidrug-resistant (MDR) A. baumannii have been reported from the United States (21, 22, 28).”
BackgroundInfluentialHirsch, E. B., Ledesma, K. R., Chang, K., Schwartz, M. S., Motyl, M. R., & Tam, V. H. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05927-11 · Cited by 145
Clinical and economic outcomes of a prospective antimicrobial stewardship program
Nowak, M. A., Nelson, R. E., Breidenbach, J. L., Thompson, P. A., & Carson, P. J. (2012) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110603 · Cited by 144
“Over the last several decades, antimicrobial-resistant organisms have been responsible for an increasing percentage of nosocomial infections.(3-5) Infections involving resistant pathogens have been shown to increase hospital length of stay (LOS), costs, and mortality.”
BackgroundLópez, J. L. G., Vilela, A. A., del Palacio, E. F., Corral, J., Martí, C. B., & Portal, P. H. (2013) · Journal of Hospital Infection · doi:10.1016/j.jhin.2013.10.008 · Cited by 167
“on hospital wards).(30,31) However, in light of the current economic crisis, the main finding of this study was the identification of indwell times for safe and effective routine replacement of PIVCs, thus saving on consumption and costs.”
BackgroundHarris, G., Lee, R. K., Lam, C. K., Kanzaki, G., Patel, G. B., Xu, H. H., & Chen, W. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00944-13 · Cited by 141
“Indeed, the United States National Nosocomial Infections Surveillance data indicate that Acinetobacter infections were responsible for 7% of intensive care unit (ICU) nosocomial cases of pneumonia in 2003 (3).”
BackgroundSharma, R., Shultz, S. R., Robinson, M. J., Belli, A., Hibbs, M. L., O'Brien, T. J., & Semple, B. D. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.04.034 · Cited by 146
Isolation and characterization of ϕAB2: a novel bacteriophage of Acinetobacter baumannii
Lin, N., Chiou, P.-Y., Chang, K., Chen, L., & Lai, M. (2010) · Research in Microbiology · doi:10.1016/j.resmic.2010.03.007 · Cited by 140
“…in intensive care units (ICUs), as being the cause of outbreaks of nosocomial infections such as bloodstream infections, ventilator-acquired pneumonia, meningitis, urinary tract infections and wound infections (BergogneBerezin and Towner, 1996; Gaynes and Edwards, 2005; Joly-Guillou, 2005).”
BackgroundNicasio, A. M., Kuti, J. L., & Nicolau, D. P. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.2.235 · Cited by 155
Development of Quorum-Based Anti-Virulence Therapeutics Targeting Gram-Negative Bacterial Pathogens
Tay, S. B., & Yew, W. S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140816570 · Cited by 155
Tan, C.-H., Li, J., & Nation, R. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01571-06 · Cited by 138
“Multidrug-resistant (MDR) Acinetobacter baumannii has emerged in recent times as a major cause of nosocomial infections worldwide (4, 6, 20, 24, 25), particularly in patients who are critically ill or immunocompromised.”
BackgroundCefepime: a reappraisal in an era of increasing antimicrobial resistance
Endimiani, A., Pérez, F., & Bonomo, R. A. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.6.805 · Cited by 137
“12 N R [4 2] #”
BackgroundInfluentialKlevens, R. M., Edwards, J. R., Gaynes, R. P., & System, N. N. I. S. (2008) · Clinical Infectious Diseases · doi:10.1086/591698 · Cited by 136
Self-citationHamouda, A., Evans, B. A., Towner, K. J., & Amyes, S. G. B. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02431-09 · Cited by 136
Zilberberg, M. D., & Shorr, A. F. (2013) · Infection Control and Hospital Epidemiology · doi:10.1086/671740 · Cited by 149
Emergence of antimicrobial resistance among Acinetobacter species: a global threat
Clark, N. M., Zhanel, G. G., & Lynch, J. P. (2016) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000337 · Cited by 134
Bai, H., You, Y., Hua, Y., Meng, J., Xue, X., Hou, Z., Zhou, Y., Ma, X., Sang, G., & Luo, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.075 · Cited by 134
Young, K., Painter, R. E., Raghoobar, S. L., Hairston, N. N., Racine, F., Wisniewski, D., Balibar, C. J., Villafania, A., Zhang, R., Sahm, D. F., et al. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1522-7 · Cited by 132
Hasan, J., Xu, Y., Yarlagadda, T., Schuetz, M., Spann, K. M., & Yarlagadda, P. K. D. V. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00348 · Cited by 132
McConnell, M. J., Domínguez-Herrera, J., Smani, Y., López-Rojas, R., Docobo-Pérez, F., & Pachón, J. (2010) · Infection and Immunity · doi:10.1128/iai.00741-10 · Cited by 143
“2% of bacteremias in intensive care units (14, 39).”
BackgroundResultLactoferrin-lipopolysaccharide (LPS) binding as key to antibacterial and antiendotoxic effects
Drago-Serrano, M. E., de la Garza-Amaya, M., Serrano‐Luna, J., & Campos‐Rodríguez, R. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.11.002 · Cited by 142
Inhaled antimicrobial therapy – Barriers to effective treatment
Weers, J. G. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.08.013 · Cited by 133
Zhang, Y., Chen, X.-L., Ai-wei, H., Liu, S., Liu, W., Zhang, N., & Lu, X. (2016) · Emerging Microbes & Infections · doi:10.1038/emi.2016.22 · Cited by 152
Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond
Weber, B. S., Harding, C. M., & Feldman, M. F. (2015) · Journal of Bacteriology · doi:10.1128/jb.00906-15 · Cited by 144
Poulikakos, P., Tansarli, G. S., & Falagas, M. E. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2124-9 · Cited by 125
Prospects for the next anti-Pseudomonas drug
Page, M. G. P., & Heim, J. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.08.006 · Cited by 125
Al‐Hasan, M. N., Lahr, B. D., Eckel-Passow, J. E., & Baddour, L. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp162 · Cited by 125
“514 Ciprofloxacin 0/87 (0) 4/80 (5) 9/103 (9) 7/98 (7) 11/91 (12) 31/459 (7) 0.”
Role of Macrophages in Early Host Resistance to Respiratory Acinetobacter baumannii Infection
Qiu, H., KuoLee, R., Harris, G., van Rooijen, N., Patel, G. B., & Chen, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040019 · Cited by 125
“nistic pathogen that frequently induces nosocomial and community-acquired pneumonia, skin and urinary tract infections, and bacteremia [1–3], especially in immunocompromised individuals [4].”
BackgroundLinares, L., Cervera, C., Cofán, F., Ricart, M. J., Esforzado, N., Torregrosa, V., Oppenheimer, F., Campistol, J. M., Marco, F., & Moreno, A. (2007) · Transplantation Proceedings · doi:10.1016/j.transproceed.2007.06.061 · Cited by 136
Jiang, Z., Vasil, A. I., Gera, L., Vasil, M. L., & Hodges, R. S. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01086.x · Cited by 122
“Acinetobacter baumannii and Pseudomonas aeruginosa are two increasingly problematic hospital-associated Gram-negative pathogens because of dramatic increases in the incidence of antibioticresistant species (1).”
InfluentialFood Spoilage by Pseudomonas spp.—An Overview
Raposo, A., Pérez, E., de Faria, C. T., Ferrús, M. A., & Carrascosa, C. (2016) · Wiley eBooks · doi:10.1002/9781119139188.ch3 · Cited by 150
Class C β-Lactamases: Molecular Characteristics
Philippon, A., Arlet, G., Labia, R., & Iorga, B. I. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00150-21 · Cited by 138
über, W. F. D. M. G. K. G. (2010) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-010-1028-9 · Cited by 133
Pseudomonas aeruginosa – Pathogenesis and Pathogenic Mechanisms
Alhazmi, A. (2015) · International Journal of Biology · doi:10.5539/ijb.v7n2p44 · Cited by 175
“According to report by the National Nosocomial Infections Surveillance (NNIS) System, which focused on nosocomial infections in ICU, not only were resistance rates increasing, but the incidence of occurrence of most infection types was also increasing (Gaynes and Edwards, 2005).”
ResultMiller, D. L., & O’Grady, N. P. (2012) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2012.04.023 · Cited by 118
Labarca, J. A., Salles, M. J. C., Seas, C., & Guzmán-Blanco, M. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.940494 · Cited by 118
Emerging Resistant Gram-Negative Aerobic Bacilli in Hospital-Acquired Infections
Kunz, A. N., & Brook, I. (2010) · Chemotherapy · doi:10.1159/000321018 · Cited by 115
“The NNIS reported a 6.9p increase in Acinetobacter species causing hospital-acquired pneumonias in ICUs in 2003 (up from 1.4p in 1975), along with an increase in bloodstream infections, urinary tract infections and surgical site infections [”
BackgroundAcinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D
Stahl, J., Bergmann, H., Göttig, S., Ebersberger, I., & Averhoff, B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138360 · Cited by 110
Xiao, F., Cao, B., Wang, C., Guo, X., Li, M., Xing, D., & Hu, X. (2019) · ACS Nano · doi:10.1021/acsnano.8b07251 · Cited by 117
RetractedJefferies, J. M., Cooper, T., Yam, T., & Clarke, S. C. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.044818-0 · Cited by 131
Lautenbach, E., Synnestvedt, M. B., Weiner, M. G., Bilker, W. B., Vo, L., Schein, J. R., & Kim, M. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/649021 · Cited by 140
Chow, J. Y., Yang, Y., Tay, S. B., Chua, K. L., & Yew, W. S. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02410-13 · Cited by 117
Pachón-Ibáñez, M. E., Docobo-Pérez, F., López-Rojas, R., Domínguez-Herrera, J., Me, J.-M., García-Curiel, A., Pichardo, C., Jiménez, L., & Pachón, J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00367-09 · Cited by 114
Fu, Y., Zhou, J., Zhou, H., Yang, Q., Wei, Z., Yu, Y., & Li, L. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq027 · Cited by 112
Antimicrobial acrylic materials with in situ generated silver nanoparticles
Oei, J. D., Zhao, W. W., Chu, L., DeSilva, M., Ghimire, A., Rawls, H. R., & Whang, K. (2011) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31963 · Cited by 122
Hamad, P. A., & Khadija, K. M. (2019) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2019.041 · Cited by 111
Tam, V. H., Gamez, E. A., Weston, J. S., Gerard, L. N., LaRocco, M., Caeiro, J. P., Gentry, L. O., & Garey, K. W. (2008) · Clinical Infectious Diseases · doi:10.1086/528712 · Cited by 110
“3%) in patients with nosocomial urinary tract infections in the United States [1], Treatment of infections due to”
BackgroundKim, D. H., Choi, J.-Y., Kim, H. W., Ys, K., Chung, D. R., Peck, K. R., Thamlikitkul, V., So, T. M.-K., Yasin, R. M., Hsueh, P., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-13 · Cited by 109
“8) 21 2 TH (11), MY (7), KR (2), SG (1), TW (1), HK (1) AbaR25-II ( Tn2006) 3 (4.”
Caselli, D., Cesaro, S., Ziino, O., Zanazzo, G. A., Manicone, R., Livadiotti, S., Cellini, M., Frenos, S., Milano, G. M., Cappelli, B., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.020867 · Cited by 109
Kohlenberg, A., Brümmer, S., Higgins, P. G., Sohr, D., Piening, B., de Grahl, C., Halle, E., Rüden, H., & Seifert, H. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.012302-0 · Cited by 107
“…representatives of each PFGE type were analysed further by the repetitive-sequence-based PCR (rep-PCR) DiversiLab microbial typing system (bioMérieux), a semi-automated PCR technique that amplifies the regions between the non-coding repetitive sequences in bacterial genomes (Healy et al., 2005).”
MethodKhan, S., Mohammed Rayis, P., Rizvi, A., Alam, M. M., Rizvi, M., & Naseem, I. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.01.003 · Cited by 105
Impact of wars and natural disasters on emerging and re-emerging infectious diseases
Topluoğlu, S., Özkan, A. T., & Alp, E. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1215929 · Cited by 117
Russo, T. A., MacDonald, U., Beanan, J. M., Olson, R., MacDonald, I. J., Sauberan, S. L., Luke, N. R., Schultz, L. W., & Umland, T. C. (2009) · The Journal of Infectious Diseases · doi:10.1086/596317 · Cited by 100
“Importantly, the incidence of Acinetobacter infection is increasing worldwide [3, 5, 6].”
BackgroundRodríguez‐Baño, J., García, L., Ramírez, E., Martínez-Martínez, L., Muniain, M. A., Fernández-Cuenca, F., Beltrán, M., Gálvez-Acebal, J., Rodríguez, J. M., Velasco, C., et al. (2009) · American Journal of Infection Control · doi:10.1016/j.ajic.2009.01.008 · Cited by 111
Transcriptome Profiling of Antimicrobial Resistance in Pseudomonas aeruginosa
Khaledi, A., Schniederjans, M., Pohl, S., Rainer, R. J., Bodenhofer, U., Xia, B., Klawonn, F., Bruchmann, S., Preuße, M., Eckweiler, D., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00075-16 · Cited by 113
Ding, C., Yang, Z., Wang, J., Liu, X., Cao, Y., Pan, Y., Han, L., & Zhan, S. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.06.014 · Cited by 115
Harris, A. D., McGregor, J. C., & Furuno, J. P. (2006) · Clinical Infectious Diseases · doi:10.1086/504479 · Cited by 102
Deckman, J. M., Meissler, J. J., Robinson, R. H., Spence, P. B., Truant, A., Gaughan, J. P., & Eisenstein, T. K. (2011) · Infection and Immunity · doi:10.1128/iai.00069-11 · Cited by 101
VIM-1 Metallo-β-lactamase inAcinetobacter baumannii
Tsakris, A., Ikonomidis, A., Pournaras, S., TZOUVELEKIS, L. S., Sofianou, D., Legakis, N. J., & Maniatis, A. N. (2006) · Emerging infectious diseases · doi:10.3201/eid1206.051097 · Cited by 101
The Secrets of Acinetobacter Secretion
Weber, B. S., Kinsella, R. L., Harding, C. M., & Feldman, M. F. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.01.005 · Cited by 109
Antimicrobial Stewardship in the Hospital Setting: A Narrative Review
Giamarellou, H., Galani, L., Karavasilis, T., Ioannidis, K., & Karaiskos, I. (2023) · Antibiotics · doi:10.3390/antibiotics12101557 · Cited by 118
Sahly, H., Navon‐Venezia, S., Roesler, L., Hay, A., Carmeli, Y., Podschun, R., Hennequin, C., Forestier, C., & Ofek, I. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00010-08 · Cited by 99
Falagas, M. E., & Karveli, E. A. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01596.x · Cited by 99
The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia
Eveillard, M., Soltner, C., Kempf, M., Saint‐André, J., Lemarié, C., Randrianarivelo, C., Seifert, H., Wolff, M., & Joly‐Guillou, M. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.09.004 · Cited by 106
Zilberberg, M. D., & Shorr, A. F. (2013) · Journal of Hospital Medicine · doi:10.1002/jhm.2080 · Cited by 97
Wei, X., Ran, D., Campeau, A., Xiao, C., Zhou, J., Dehaini, D., Jiang, Y., Kroll, A. V., Zhang, Q., Gao, W., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01844 · Cited by 99
Marsden, A. E., Intile, P. J., Schulmeyer, K. H., Simmons-Patterson, E. R., Urbanowski, M. L., Wolfgang, M. C., & Yahr, T. L. (2016) · Journal of Bacteriology · doi:10.1128/jb.00049-16 · Cited by 85
Gabriel, A., Shores, J. T., Bernstein, B., de Leon, J., Kamepalli, R., Wolvos, T. A., Baharestani, M. M., & Gupta, S. C. (2009) · International Wound Journal · doi:10.1111/j.1742-481x.2009.00628.x · Cited by 96
Lupo, A., Papp‐Wallace, K. M., Sendi, P., Bonomo, R. A., & Endimiani, A. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.06.001 · Cited by 106
“Escherichia coli is a frequent cause of urinary tract infections, Klebsiella spp. and Enterobacter spp. are important causes of nosocomial pneumonia, and all of the Ent have been implicated in bloodstream (BSIs) and intra-abdominal infections (Donnenberg, 2005; Gaynes and Edwards, 2005).”
BackgroundOne stone, three birds: one AIEgen with three colors for fast differentiation of three pathogens
Zhou, C., Jiang, M., Du, J., Bai, H., Shan, G., Kwok, R. T. K., Chau, J. H. C., Zhang, J., Lam, J. W. Y., Huang, P., et al. (2020) · Chemical Science · doi:10.1039/d0sc00256a · Cited by 96
Anyan, M. E., Amiri, A., Harvey, C. W., Tierra, G., Morales-Soto, N., Driscoll, C. M., Alber, M., & Shrout, J. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414661111 · Cited by 110
Mortensen, B. L., Rathi, S., Chazin, W. J., & Skaar, E. P. (2014) · Journal of Bacteriology · doi:10.1128/jb.01650-14 · Cited by 94
“fections, predominately in intensive care units (1, 2).”
BackgroundAn Organ System-Based Synopsis of Pseudomonas aeruginosa Virulence
Morin, C. D., Déziel, É., Gauthier, J., Lévesque, R. C., & Lau, G. W. (2021) · Virulence · doi:10.1080/21505594.2021.1926408 · Cited by 111
Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia
Michels, K. R., Zhang, Z., Bettina, A. M., Cagnina, R. E., Stefanova, D., Burdick, M. D., Vaulont, S., Nemeth, E., Ganz, T., & Mehrad, B. (2017) · JCI Insight · doi:10.1172/jci.insight.92002 · Cited by 93
“ant causes of morbidity and death in hospitalized patients (1).”
BackgroundBulitta, J. B., Ly, N. S., Yang, J. C., Forrest, A., Jusko, W. J., & Tsuji, B. T. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00489-08 · Cited by 98
“aeruginosa isolates from intensive care units increased from approximately 14% in 1997 to 24% in 2003 in the United States (23).”
BackgroundMolecular Design of Antifouling Polymer Brushes Using Sequence‐Specific Peptoids
Lau, K. H. A., Sileika, T. S., Park, S. H., Sousa, A. M. L., Burch, P., Szleifer, I. G., & Messersmith, P. B. (2014) · Advanced Materials Interfaces · doi:10.1002/admi.201400225 · Cited by 96
Dissemination of Acinetobacter baumannii Clones with OXA-23 Carbapenemase in Colombian Hospitals
Villegas, M. V., Kattán, J. N., Correa, A., Lolans, K., Guzmán, A. M., Woodford, N., Livermore, D. M., & Quinn, J. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00226-07 · Cited by 93
“Cali A 31 1 (21) 10 31 31 29 78/268 Bogota ´ B 12 2 ( 8 ) 4 12 12 62 43/69”
BackgroundPrimer Evaluation for PCR and its Application for Detection of Carbapenemases in Enterobacteriaceae
Mlynárčik, P., Röderová, M., & Kolář, M. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.29314 · Cited by 98
Lima, W. G., Alves, M. C., Nizer, W. S. D. C., & de Paiva, M. C. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3223-9 · Cited by 102
Thom, K. A., Johnson, J. K., Lee, M. S., & Harris, A. D. (2011) · American Journal of Infection Control · doi:10.1016/j.ajic.2010.09.005 · Cited by 92
“Acinetobacter baumannii has emerged as an important nosocomial pathogen, and infection with this organism has been associated with increased patient morbidity, mortality, and health care costs.(1,2) Despite current standard practices in infection control, such as the use of barrier precautions and emphasis on”
Serum resistance and biofilm formation in clinical isolates ofAcinetobacter baumannii
King, L. B., Swiatlo, E., Swiatlo, A. L., & McDaniel, L. S. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00538.x · Cited by 90
Park, D., Kim, J., Lee, Y. M., Park, J., & Kim, W. J. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600150 · Cited by 89
Infections Due to Acinetobacter baumannii in the ICU: Treatment Options
Zhanel, G. G., Clark, N. M., & Lynch, J. P. (2017) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1599225 · Cited by 89
Sader, H. S., Castanheira, M., Flamm, R. K., Mendes, R. E., Farrell, D. J., & Jones, R. N. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.02.022 · Cited by 89
Waites, K. B., Duffy, L. B., & Dowzicky, M. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00210-06 · Cited by 89
“give cause for concern due to their innate resistance to many antimicrobials (9, 10).”
BackgroundUpdate on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections
Kim, U. J., Kim, H. K., An, J. H., Cho, S. K., Park, K., & Jang, H. (2014) · Chonnam Medical Journal · doi:10.4068/cmj.2014.50.2.37 · Cited by 119
Johnson, J. K., Smith, G., Lee, M. S., Venezia, R. A., Stine, O. C., Nataro, J. P., Hsiao, W., & Harris, A. D. (2009) · The Journal of Infectious Diseases · doi:10.1086/605408 · Cited by 87
“aeruginosa strains with resistance to carbapenems has significantly increased over time, thus limiting treatment options [1].”
Tipton, K. A., Chin, C., Farokhyfar, M., Weiss, D. S., & Rather, P. N. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01188-18 · Cited by 87
Jeon, J., & Yong, D. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.02900-18 · Cited by 87
“XDR Pseudomonas aeruginosa is one of the most common Gram-negative pathogens causing nosocomial infections and is a major public health concern because it possesses numerous resistance mechanisms, including beta-lactamases, carbapenemases, and efflux pumps (33, 34).”
BackgroundChai, M., Gao, Y., Liu, J., Deng, Y., Hu, D., Jin, Q., & Ji, J. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901542 · Cited by 86
Mera, R. M., Miller, L. A., Amrine‐Madsen, H., & Sahm, D. F. (2010) · Microbial Drug Resistance · doi:10.1089/mdr.2010.0052 · Cited by 85
“8 The reported increased incidence of A. baumannii infections 12 has been attributed to the advances in support of critically ill and frail patients.”
Genetic Determinants of Intrinsic Colistin Tolerance in Acinetobacter baumannii
Hood, M. I., Becker, K. W., Roux, C. M., Dunman, P. M., & Skaar, E. P. (2012) · Infection and Immunity · doi:10.1128/iai.00704-12 · Cited by 93
Yehya, A., Ezzeddine, Z., Chakkour, M., Dhaini, Z., Saba, M. S. B., Saba, A. S. B., Nohra, L., Nassar, N. B., Yassine, M., Bahmad, H. F., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1565965 · Cited by 93
Metadata
- Authors
- Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-15
- Volume
- 41
- Issue
- 6
- Pages
- 848-854
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2151958462
- Cited by
- 1,404
- References
- 26
- Citations by year
- 2026: 14 · 2025: 21 · 2024: 37 · 2023: 56 · 2022: 73 · 2021: 80 · 2020: 66 · 2019: 78 · 2018: 66 · 2017: 74 · 2016: 86 · 2015: 89 · 2014: 85 · 2013: 95 · 2012: 85
- FWCI
- 38.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- nosocomial infections, Gram-negative bacilli, intensive care unit, surgical site infection, urinary tract infection, bloodstream infection, Acinetobacter, antimicrobial resistance, epidemiological trends
- MeSH terms
- Cross Infection, Gram-Negative Bacteria, Humans, National Health Programs, Population Surveillance, Surgical Wound Infection, Time Factors, United States, Urinary Tract Infections, Gram-Negative Bacterial Infections, Pneumonia, Bacterial, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.